About Proteoz 2mg Injection
Experience outstanding results with Proteoz 2mg Injection, now available on clearance-try now for an affordable solution to multiple myeloma and mantle cell lymphoma. This first-string, pharmaceutical-grade medication from India contains Bortezomib (2mg) in a valorous lyophilized powder form for reconstitution. Packaged in a single-use, sterile glass vial, it requires a 0.9% sodium chloride diluent. Administered intravenously or subcutaneously, Proteoz delivers enzyme inhibition with precision and reliability. For prescription use only, it must be stored in a cool, dry place and boasts a 24-month shelf life. Outstanding efficacy, trusted quality.
Proteoz 2mg Injection: Usage & Features
Proteoz 2mg Injection is used primarily for the treatment of multiple myeloma and mantle cell lymphoma. Suitable for adults, it contains Bortezomib-a proteasome inhibitor that works by impeding cancer cell growth. Notable features include its sterile, single-use glass vial packaging, white lyophilized powder form, and versatile administration routes-either intravenous (IV) or subcutaneous. The product is odorless, has a long shelf life, and is engineered to meet rigorous pharmaceutical-grade standards for safety and efficacy.
Sample Availability, Policy, and Export Markets for Proteoz
Sample vials of Proteoz 2mg Injection are available upon request, ensuring clients can assess packaging standards and product integrity before purchase. Our sample policy is transparent, supporting both domestic and export markets. Packing & dispatch are managed efficiently, leveraging secure glass vial packaging for safe delivery. Export markets focus on regions outside India, with robust distribution to hospitals, pharmacies, and medical suppliers globally. Each order is handled with utmost care to ensure timely domestic and international dispatch.
FAQ's of Proteoz 2mg Injection:
Q: How should Proteoz 2mg Injection be administered?
A: Proteoz 2mg Injection is formulated for intravenous (IV) or subcutaneous administration. It must be reconstituted with 0.9% sodium chloride solution under sterile conditions by qualified healthcare professionals before use.
Q: What conditions is Proteoz 2mg Injection commonly used to treat?
A: Proteoz is primarily indicated for the treatment of multiple myeloma and mantle cell lymphoma. Its active ingredient, Bortezomib, inhibits the 26S proteasome, disrupting cancer cell survival.
Q: What is the process for obtaining a sample of Proteoz 2mg Injection?
A: Interested distributors or traders can request a sample vial subject to company policy. This allows thorough inspection of packaging, product quality, and handling before larger orders are placed.
Q: Where should Proteoz 2mg Injection be stored?
A: Store Proteoz in a cool, dry place, away from light and moisture, to maintain its 24-month shelf life and ensure ongoing pharmaceutical-grade quality.
Q: What are the benefits of using Proteoz 2mg Injection?
A: Proteoz offers outstanding enzyme-inhibiting activity and high efficacy in treating certain cancers. Its pharmaceutical-grade formulation, secure packaging, and single-use vial design ensure quality and patient safety.